Cargando…

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.

Patients with inactive or occult hepatitis B virus infection and onco-hematological malignancies are at risk of hepatitis flare, hepatic failure and death due to chemotherapy-mediated reactivation. Nucleot(s)ide analogues can reduce reactivation risks and/or hepatitis. However, immuno-mediated pheno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marzano, Alfredo, Marengo, Andrea, di Fonzo, Michela, Begini, Paola, Ferrari, Antonella, Monarca, Bruno, delle Fave, Gianfranco, Marignani, Massimo
Formato:	Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033103/ https://www.ncbi.nlm.nih.gov/pubmed/21415953 http://dx.doi.org/10.4084/MJHID.2010.035

Ejemplares similares

Hepatitis B in patients with hematological diseases: An update
por: Coluccio, Chiara, et al.
Publicado: (2017)

Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management
por: Zannella, Alessandra, et al.
Publicado: (2019)

Surgical Management of Rhinosinusitis in Onco-Hematological Patients
por: Di Girolamo, Stefano, et al.
Publicado: (2014)

Two cases of paralitic ileus in onco-hematologic patients
por: Carraro, Francesca, et al.
Publicado: (2012)

Safety of switching between rituximab biosimilars in onco-hematology
por: Urru, Silvana A. M., et al.
Publicado: (2021)

Editorial: Real-World evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2022)

COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study
por: Zannella, Alessandra, et al.
Publicado: (2022)

Top-ten infections in onco-hematological patients (2015-2017)
por: Camps, Isabel Ruiz, et al.
Publicado: (2019)

Health Related Quality of Life in Patients with Onco-hematological Diseases
por: La Nasa, Giorgio, et al.
Publicado: (2020)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
por: Elvira, David, et al.
Publicado: (2023)

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
por: Cerva, Carlotta, et al.
Publicado: (2022)

Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
por: Crisci, Stefania, et al.
Publicado: (2019)

The profile of the onco-hematology patient in the palliative care: 4 years of experience
por: Couto, Maria Eduarda, et al.
Publicado: (2019)

Pediatric onco-hematological home care during COVID-19 pandemic
por: Amicucci, Matteo, et al.
Publicado: (2021)

Editorial: Digital health and real-world evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2023)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Italian nurses knowledge and attitudes towards fatigue in pediatric onco-hematology: A cross-sectional nationwide survey
por: Rostagno, Elena, et al.
Publicado: (2020)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

Hypergastrinemia and enterochromaffin-like cell hyperplasia.
por: Delle Fave, G., et al.
Publicado: (1998)

Management of HBV Infection During Immunosuppressive Treatment
por: Marzano, Alfredo
Publicado: (2009)

Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia
por: Ribeiro, A.F. Tibúrcio, et al.
Publicado: (2013)

Virtual Reality Analgesia During Venipuncture in Pediatric Patients With Onco-Hematological Diseases
por: Atzori, Barbara, et al.
Publicado: (2018)

Cardio-onco-hematology patients’ management in the context of the current COVID-19 pandemic
por: Lorca, Rebeca, et al.
Publicado: (2020)

Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases
por: de Almeida, João Bosco, et al.
Publicado: (2023)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
por: Molagic, Violeta, et al.
Publicado: (2013)

Review of a three-year study on the dental care of onco-hematological pediatric patients
por: Frascino, Alexandre Viana, et al.
Publicado: (2018)

Depression and burden in caregivers of onco-hematologic patients during SARS-Cov-2 pandemic
por: Di Perna, M., et al.
Publicado: (2023)

PB2683: MODERN DIAGNOSTIC CAPABILITIES OF THE OPHTHALMOLOGICAL STATUS OF PATIENTS WITH ONCO-HEMATOLOGICAL DISEASES.
por: Yusef, Yusef N, et al.
Publicado: (2023)

Exocrine Pancreatic Insufficiency in Diabetic Patients: Prevalence, Mechanisms, and Treatment
por: Piciucchi, Matteo, et al.
Publicado: (2015)

Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology
por: Zaccaria, Gian Maria, et al.
Publicado: (2021)

Feasibility of tumor-derived exosome enrichment in the onco-hematology leukemic model of chronic myeloid leukemia
por: Bernardi, Simona, et al.
Publicado: (2019)

Role of Sirtuins in the Pathobiology of Onco-Hematological Diseases: A PROSPERO-Registered Study and In Silico Analysis
por: Goes, João Vitor Caetano, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper
por: Bouza, Emilio, et al.
Publicado: (2022)

Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?
por: Mouawad, Nayla, et al.
Publicado: (2023)

Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma
por: Liu, Jian, et al.
Publicado: (2023)

Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis
por: Merola, Elettra, et al.
Publicado: (2017)

PyOncoPrint: a python package for plotting OncoPrints
por: Park, Jeongbin, et al.
Publicado: (2023)

Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis
por: Li, Ping, et al.
Publicado: (2021)

Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b6kvjq7s9ntbhjviij0pcca8g8